845626-17-7 Usage
Chemical composition
The compound consists of an ethyl group, a piperidin-yl group, and a urea group, all linked together to form a hydrochloride salt.
Pharmaceutical research
1-Ethyl-3-(piperidin-4-yl)urea hydrochloride is commonly used in pharmaceutical research and drug development.
Central nervous system stimulant
The compound is known for its potential as a central nervous system stimulant.
Therapeutic effects
It has been studied for its possible therapeutic effects on conditions such as depression, anxiety, and cognitive impairment.
Substance abuse and addiction
The compound has been investigated as a potential treatment for substance abuse and addiction.
Mechanisms of action
The precise mechanisms of action for 1-Ethyl-3-(piperidin-4-yl)urea hydrochloride are still under investigation.
Side effects
The potential side effects of the compound are also under investigation.
Drug candidate
1-Ethyl-3-(piperidin-4-yl)urea hydrochloride shows promise as a drug candidate for various neurological and psychiatric disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 845626-17-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,5,6,2 and 6 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 845626-17:
(8*8)+(7*4)+(6*5)+(5*6)+(4*2)+(3*6)+(2*1)+(1*7)=187
187 % 10 = 7
So 845626-17-7 is a valid CAS Registry Number.
845626-17-7Relevant articles and documents
Rifamycin analogs and uses thereof
-
Page/Page column 32-33, (2008/06/13)
The present invention features rifamycin analogs that can be used as therapeutics for treating or preventing a variety of microbial infections. In one form, the analogs are acetylated at the 25-position, as is rifamycin. In another form, the analogs are deacetylated at the 25-position. In yet other forms, benzoxazinorifamycin, benzthiazinorifamycin, and benzdiazinorifamycin analogs are derivatized at various positions of the benzene ring, including 3′-hydroxy analogs, 4′-and/or 6′ halo and/or alkoxy analogs, and various 5′ substituents that incorporate a cyclic amine moiety.
